NanoCarrier Competitors and Similar CompaniesClear all

NanoCarrier's competitors and similar companies include LiPlasome Pharma, Corvus Pharmaceuticals, RS Research and Oncolinx.
NanoCarrier
NanoCarrier
NanoCarrier (ナノキャリア株式会社) is a company engaged in the research and development of pharmaceuticals using micellar nanoparticle technology.
LiPlasome Pharma
LiPlasome Pharma
LiPlasome Pharma is a biotech company focused on oncology.
Corvus Pharmaceuticals
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.
RS Research
RS Research
RS Research is a pharmaceutical company developing nanomedicines based on innovative drug delivery platforms for targeted cancer therapy.
Oncolinx
Oncolinx
Oncolinx is a company developing antibody-drug conjugates (ADCs).
Founding Date
Founding Date
1996
Founding Date
2002
Founding Date
2014
Founding Date
2015
Founding Date
2013
Type
Type
Public
Type
Subsidiary
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
柏市, JP HQ
Chuo City, JP
Locations
Hørsholm, DK HQ
Locations
Burlingame, US HQ
Locations
Epalinges, CH HQ
Locations
HQ
Employees
Employees
18
Employees
13
Employees
4911% decrease
Employees
254% decrease
Employees
3
Valuation ($)
Valuation ($)
78 m
Valuation ($)
N/A
Valuation ($)
556.1 m
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Net income
Net income
(¥835.4m) (FY, 2025)
Net income
N/A
Net income
($15.3m) (FY, 2025)
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 8m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 1.1m
For sources of this data, please see the company profile

View Company Profiles

LiPlasome Pharma
HQ
Hørsholm, DK

LiPlasome Pharma is a biotech company focused on oncology.

View company
Corvus Pharmaceuticals
HQ
Burlingame, US
Employees
49↓ 11% decrease

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.

View company
RS Research
HQ
Epalinges, CH
Employees
25↓ 4% decrease

RS Research is a pharmaceutical company developing nanomedicines based on innovative drug delivery platforms for targeted cancer therapy.

View company
Oncolinx
HQ
Employees
3

Oncolinx is a company developing antibody-drug conjugates (ADCs).

View company